On?October?31,?2005,?Pfizer?announced?the?official?opening?of?China?Research?and?Development?Center?(CRDC)?in?Shanghai.?Pfizer?Global?Research?and?Development’s?Center?is?mainly?engaged?in?drug?development?activities.?Much?of?the?facilitys?capacity?is?devoted?to?the?study?design,?data?management?and?statistical?analysis?of?global?phase?I-IV?clinical?trials,?as?well?as?the?clinical?study?report?process.?In?addition,?CRDC?is?a?part?of?Pfizer?global?Safety?and?Risk?Management?and?covers?the?functions?of?safety?data?processing?and?assessment.?The?center?also?trains?Pfizer?employees?in?China?and?throughout?the?Asia?region?in?internationally?recognized?Good?Clinical?Practice?standards.
輝瑞公司于2005年10月31日宣布輝瑞中國(guó)研發(fā)中心正式在上海揭幕。輝瑞中國(guó)研發(fā)中心主要為全球輝瑞藥物開發(fā)提供支持工作。大部分的功能是圍繞在I-IV期臨床試驗(yàn)研究設(shè)計(jì)、數(shù)據(jù)管理和生物統(tǒng)計(jì)分析、以及臨床試驗(yàn)報(bào)告的部分準(zhǔn)備工作。此外，該中心是輝瑞全球安全和風(fēng)險(xiǎn)管理部的一個(gè)分支，負(fù)責(zé)安全數(shù)據(jù)處理和評(píng)估工作。研發(fā)中心還將為輝瑞公司在中國(guó)及亞洲的其它運(yùn)營(yíng)部門的員工提供國(guó)際標(biāo)準(zhǔn)的臨床試驗(yàn)管理規(guī)范(GCP)的技術(shù)培訓(xùn)。